Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Brachytherapy|May 9, 2017
Magnetic resonance imaging-based salvage brachytherapy: Moving toward a focal paradigmMarisa A Kollmeier, Michael Zelefsky, Sean McBride
Physics in Medicine and Biology|October 5, 2006
Principal component, Varimax rotation and cost analysis of volume effects in rectal bleeding in patients treated with 3D-CRT for prostate cancerJ D Bauer, Andrew Jackson, Mark Skwarchuk, et al.
Medical Physics|May 6, 2016
Optimizing fiducial visibility on periodically acquired megavoltage and kilovoltage image pairs during prostate volumetric modulated arc therapyPengpeng Zhang, Laura Happersett, Bosky Ravindranath, et al.
Physics and Imaging in Radiation Oncology|December 24, 2024
Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapyErgys Subashi, Eve LoCastro, Sarah Burleson, et al.
Seminars in Radiation Oncology|June 7, 2020
To Radiate or Not to Radiate-The Challenges of Pelvic ReirradiationSophia C Kamran, Michael Zelefsky, Paul L Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Volumetric modulated arc therapy: planning and evaluation for prostate cancer casesPengpeng Zhang, Laura Happersett, Margie Hunt, et al.
Physics in Medicine and Biology|October 23, 2013
Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapyPengpeng Zhang, Margie Hunt, Laura Happersett, et al.
Medical Physics|March 1, 2023
Deep learning-based dominant index lesion segmentation for MR-guided radiation therapy of prostate cancerJosiah Simeth, Jue Jiang, Anton Nosov, et al.
Head & Neck|January 13, 2015
Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapyJohn Cuaron, Shyam Rao, Suzanne Wolden, et al.
Cancer|November 8, 2008
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811William Kevin Kelly, Susan Halabi, Aymen Elfiky, et al.
Pageof 4